Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | IGF1R | P08069 | 1/20 | 0.31 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3538222 | 0.84 | HSP90AA1 (0.38) | HSP90AA1NPC1RAB9AIGF1RCISD1 | |
| SCHEMBL3531495 | 0.83 | — | — | |
| SCHEMBL3529911 | 0.83 | HSP90AA1 (0.38) | HSP90AA1IGF1RCISD1CYP1A2CYP2C9 | |
| SCHEMBL5834099 | 0.82 | NPC1 (0.38) | HSP90AA1NPC1RAB9ACYP1A2CYP2C9 | |
| SCHEMBL4578543 | 0.80 | POLB (0.44) | NPC1RAB9AIGF1RCISD1CYP1A2 | |
| SCHEMBL29350736 | 0.77 | NPC1 (0.49) | HSP90AA1NPC1RAB9ACYP1A2CYP2C9 | |
| SCHEMBL22080762 | 0.77 | HSP90AA1 (0.39) | HSP90AA1NPC1RAB9ACYP1A2CYP2C9 | |
| SCHEMBL22080832 | 0.77 | HSP90AA1 (0.39) | HSP90AA1NPC1RAB9ACYP1A2CYP2C9 | |
| SCHEMBL29708 | 0.77 | NPC1 (0.49) | HSP90AA1NPC1RAB9ACYP1A2CYP2C9 | |
| SCHEMBL11079994 | 0.77 | NPC1 (0.38) | HSP90AA1NPC1RAB9ACYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060083945-A1 | New luminescent compositions and their uses | HITACHI CHEMICAL CO. LTD. (JP) | 2006-04-20 | — | — | US | claimed |
| WO-2006041221-A1 | NEW LUMINESCENT COMPOSITIONS AND THEIR USES | HITACHI CHEMICAL CO., LTD. (JP) | 2006-04-20 | — | — | WO | claimed |
| US-7714099-B2 | Luminescent compositions and their uses | HITACHI CHEMICAL CO., LTD. (JP) | 2010-05-11 | — | — | US | disclosed |
| WO-2006041221-A1 | NEW LUMINESCENT COMPOSITIONS AND THEIR USES | HITACHI CHEMICAL CO., LTD. (JP) | 2006-04-20 | — | — | WO | disclosed |
| US-20060083945-A1 | New luminescent compositions and their uses | HITACHI CHEMICAL CO. LTD. (JP) | 2006-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060083945-A1 | New luminescent compositions and their uses | OCIAD1, NLRP3, OCIAD2 | HSP90AA1 4435/4885NPC1 4245/4885RAB9A 4697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.